Paul K. Audhya, CHIEF MEDICAL OFFICER at KalVista Pharmaceuticals, Inc. (KALV), sold 13,175 shares at $11.76 ($155K) on 2024-05-20, disclosed to the SEC on 2024-05-21.
Open-market sale of $155k KALV by CHIEF MEDICAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KALV | SELL | 2026-05-19 | $28K | — | Filing → |
| KALV | SELL | 2026-04-20 | $54K | — | Filing → |
| KALV | SELL | 2026-02-24 | $167K | — | Filing → |